National Cancer Institute Thesaurus

Last uploaded: February 21, 2019
Preferred Name

Sulfonylurea Antidiabetic Agent

ID

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C97936

code

C97936

DEFINITION

Sulfonamide urea derivatives with antihyperglycemic activity. Sulphonylurea antidiabetic agents bind to sulfonylurea receptor type 1 (SUR1), the subunit of ATP-sensitive inwardly-rectifier potassium (IKATP) channels on the membranes of pancreatic beta cells, thereby blocking the inward current flow (influx) of positively charged K+ ions into the cell. This results in tonic membrane depolarization, and induces a calcium ion influx through voltage-sensitive calcium channels; increased intracellular calcium ion levels trigger exocytosis of insulin-containing granules. This eventually induces secretion of insulin. The IKATP channels found in pancreatic islets are complexes of four IKATP 6.2 and four SUR1 subunits. In addition, some sulfonylureas of larger molecular size may increase the sensitivity of peripheral tissues to insulin mediated through peroxisome proliferator-activated receptor gamma (PPARgamma).

FULL_SYN

Sulphonylurea Antidiabetic Agent

label

Sulfonylurea Antidiabetic Agent

Preferred_Name

Sulfonylurea Antidiabetic Agent

prefixIRI

C97936

prefLabel

Sulfonylurea Antidiabetic Agent

Semantic_Type

Chemical Viewed Functionally

UMLS_CUI

C3273710

subClassOf

http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C29711

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
There are currently no mappings for this class.